Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Clinical and Translational Science
|
February 2, 2019
Targeting RNA: A Transformative Therapeutic Strategy
Wei Yin, Mark Rogge
Bioanalysis
|
February 22, 2013
Nonclinical development of a biosimilar: the current landscape
Anita O'Connor, Mark Rogge
Journal of Clinical Pharmacology
|
October 14, 2021
Regulation of Dietary Supplements and Nutraceutical Products in the United States: An Argument for Greater Oversight and Uniform Standards
Oliver Grundmann, Parag Kumar, Mark Rogge, et al.
Annals of Neurology
|
March 13, 2010
Reply: To PMID 19798640
James Woodworth, Meena Subramanyam, Mark Rogge
Methods in Molecular Biology (Clifton, N.J.)
|
April 19, 2022
Applications of Quantitative System Pharmacology Modeling to Model-Informed Drug Development
Andy Z X Zhu, Mark Rogge
Journal of Clinical Pharmacology
|
October 14, 2021
Front-Line Health Care Professionals Lack Critical Knowledge in Dietary Supplement and Nutraceutical Products: A Call to Action for Comprehensive Educational Opportunities
Mark Rogge, Parag Kumar, Oliver Grundmann, et al.
Nature Reviews. Drug Discovery
|
June 10, 2006
Protein therapeutics: new applications for pharmacogenetics
Cecile Krejsa, Mark Rogge, Wolfgang Sadee
Journal of Clinical Pharmacology
|
August 22, 2022
Drug Lawsuit Advertisements and the Importance of Physician Consultation Prior to Voluntary Medication Withdrawal or Transition
Kenneth T Moore, Sudhakar M Pai, Mark Rogge, et al.
European Journal of Clinical Pharmacology
|
May 3, 2007
Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers
Alain Munafo, Anthony Priestley, Ivan Nestorov, et al.
Clinical Pharmacology in Drug Development
|
May 4, 2016
Population pharmacokinetics of recombinant factor VIII Fc fusion protein
Ivan Nestorov, Srividya Neelakantan, Thomas M Ludden, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Clinical and Translational Science
|
February 2, 2019
Targeting RNA: A Transformative Therapeutic Strategy
Wei Yin, Mark Rogge
Bioanalysis
|
February 22, 2013
Nonclinical development of a biosimilar: the current landscape
Anita O'Connor, Mark Rogge
Journal of Clinical Pharmacology
|
October 14, 2021
Regulation of Dietary Supplements and Nutraceutical Products in the United States: An Argument for Greater Oversight and Uniform Standards
Oliver Grundmann, Parag Kumar, Mark Rogge, et al.
Annals of Neurology
|
March 13, 2010
Reply: To PMID 19798640
James Woodworth, Meena Subramanyam, Mark Rogge
Methods in Molecular Biology (Clifton, N.J.)
|
April 19, 2022
Applications of Quantitative System Pharmacology Modeling to Model-Informed Drug Development
Andy Z X Zhu, Mark Rogge
Journal of Clinical Pharmacology
|
October 14, 2021
Front-Line Health Care Professionals Lack Critical Knowledge in Dietary Supplement and Nutraceutical Products: A Call to Action for Comprehensive Educational Opportunities
Mark Rogge, Parag Kumar, Oliver Grundmann, et al.
Nature Reviews. Drug Discovery
|
June 10, 2006
Protein therapeutics: new applications for pharmacogenetics
Cecile Krejsa, Mark Rogge, Wolfgang Sadee
Journal of Clinical Pharmacology
|
August 22, 2022
Drug Lawsuit Advertisements and the Importance of Physician Consultation Prior to Voluntary Medication Withdrawal or Transition
Kenneth T Moore, Sudhakar M Pai, Mark Rogge, et al.
European Journal of Clinical Pharmacology
|
May 3, 2007
Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers
Alain Munafo, Anthony Priestley, Ivan Nestorov, et al.
Clinical Pharmacology in Drug Development
|
May 4, 2016
Population pharmacokinetics of recombinant factor VIII Fc fusion protein
Ivan Nestorov, Srividya Neelakantan, Thomas M Ludden, et al.
Page
of 3